logo

For the Inventor, By the Inventor

North Potomac, MD, United States of America

Edward M Rudnic

This inventor holds 48 USPTO granted patents, plus 3 CIPO patents, primarily in Oral Drug Delivery. Top assignees: Advancis Pharmaceutical Corporation, Shire Laboratories, Inc., Pharmavene, Inc.. Active years: 1994-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Edward M Rudnic. Retrieved from https://idiyas.com/inventor/edward-m-rudnic

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 48

% Patents Active = 95.8

 

Average Co-Inventor Count = 3.8

ph-index = 25

Forward Citations = 1,751(Granted Patents)


Location History:

  • Gaithersburg, MD (US) (1994)
  • No. Potomac, MD (US) (1995 - 1999)
  • North Potomac, MD (US) (1998 - 2011)
  • N. Potomac, MD (US) (2003 - 2014)
  • Potomac, MD (US) (2000 - 2020)

Company Filing History:

goldMedal24 out of 24 
 
Advancis Pharmaceutical Corporation
 patents
silverMedal14 out of 25 
 
Shire Laboratories, Inc.
 patents
bronzeMedal4 out of 5 
 
Pharmavene, Inc.
 patents
4. 2 out of 17 
 
Shionogi, Inc.
 patents
5. 1 out of 1 
 
Disposerx, Inc.
 patent
6. 1 out of 1 
 
Middlebrook Pharmaceuticals, Inc.
 patent
7. 1 out of 1 
 
Shire LLC, USA
 patent
8. 1 out of 834,513 
Other
 patents

Years Active: 1994-2020

Loading Chart...
Loading Chart...
Areas of Expertise:
Osmotic Drug Delivery
Antibiotic Formulations
Antifungal Products
Oral Pulsed Dose
Antiviral Products
Delayed Release
Solid Solution Beadlet
Antineoplastic Composition
Tetracycline Antibiotic
Fluoroquinolone Antibiotic
Metronidazole Antibiotic
Amoxicillin Composition
48 patents (USPTO):Explore Patents
1. 10532385 - Disposal of medicaments (2020-01-14),
2. 8889187 - Once a day amoxicillin product comprising immediate and delayed release dosage forms (2014-11-18),
3. 8303988 - Antifungal once-a-day product, use and formulation thereof (2012-11-06),
4. RE42096 - Oral pulsed dose drug delivery system (2011-01-31),
5. RE41148 - Oral pulsed dose drug delivery system (2010-02-22),
6. 7282221 - Antiviral product, use and formulation thereof (2007-10-16),
7. 7157095 - Multiple-delayed release antifungal product, use and formulation thereof (2007-01-02),
8. 7122204 - Antibiotic composition with inhibitor (2006-10-17),
9. 7108859 - Antineoplastic product, use and formulation thereof (2006-09-19),
10. 7105174 - Multiple-delayed release anti-neoplastic product, use and formulation thereof (2006-09-12),
11. 7074417 - Multiple-delayed release anti-viral product, use and formulation thereof (2006-07-11),
12. 7025989 - Multiple-delayed released antibiotic product, use and formulation thereof (2006-04-11),
13. 6991807 - Antibiotic composition (2006-01-31),
14. 6984401 - Antiviral product, use and formulation thereof (2006-01-10),
15. 6929804 - Anti-fungal composition (2005-08-16),

Title: Inventor Edward M Rudnic - Pioneering Innovations in Maryland

Introduction: Edward M Rudnic is a distinguished inventor based in N. Potomac, MD, known for his groundbreaking contributions to various fields.

Latest Patents: Edward M Rudnic holds several patents in the areas of technology and healthcare, showcasing his continuous commitment to innovation.

Career Highlights: With a career spanning over two decades, Edward M Rudnic has established himself as a visionary inventor, with a keen focus on developing solutions that positively impact society.

Collaborations: Throughout his career, Edward M Rudnic has collaborated with leading research institutions, universities, and companies to bring his inventions to life, fostering a culture of innovation and excellence.

Conclusion: Edward M Rudnic's passion for innovation and his relentless pursuit of excellence make him a prominent figure in the world of inventors, with a legacy that continues to inspire future generations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…